Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents, RBC Capital Markets, LLC and Evercore Group L.L.C., on the transaction. Emergent BioSolutions Inc., an American multinational specialty biopharmaceutical company headquartered in...
You must be a Standard 1 Year member to access this content.
NautaDutilh and Kirkland & Ellis advised InflaRx on the offering, and Davis Polk advised the representative of the underwriters involved. InflaRx N.V. announced a public offering...
You must be a Standard 1 Year member to access this content.
White & Case advised Ormat, and Davis Polk advised the sole book-running manager. Ormat Technologies, Inc. announced an SEC-registered follow-on offering of 3,600,000 shares of common...
You must be a Standard 1 Year member to access this content.
Skadden advised Stanley Black & Decker, and Davis Polk advised the joint book-running managers and representatives of the underwriters on the offering. Stanley Black & Decker,...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Eli Lilly, and Davis Polk advised the joint book-running managers for the offering. Eli Lilly and Company announced a registered offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk and Homburger advised ADC Therapeutics, while Cooley and Lenz & Staehelin advised the underwriter. ADC Therapeutics SA announced a registered secondary offering of 12,000,000...
You must be a Standard 1 Year member to access this content.
Davis Polk and Hogan Lovells advised Precigen on the offering, and Goodwin Procter advised the underwriters involved. Precigen Inc. announced the SEC-registered offering of an aggregate of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters in the offering. Brookdale Senior Living Inc. executed a $125 million SEC-registered offering of 2,500,000 tangible equity units. BofA...
You must be a Standard 1 Year member to access this content.
White & Case advised Ormat Technologies, Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. Kirkland advised ORIX Corporation....
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented NextGen Healthcare, while Davis Polk advised J.P. Morgan Securities LLC, the representative of the initial purchasers in the offering. NextGen Healthcare, Inc....
You must be a Standard 1 Year member to access this content.
